Polypharmacy Risk Reduction

The following tools, resources and guidelines have been compiled to support a team approach to reducing risk from polypharmacy in residential care, acute care, and in the community. Some resources have been designed to be adapted to your own individual setting if required. 

In this Section


Tools, Guidelines, Resources

Through experience gained as one of the prototypes for the Polypharmacy Risk Reduction initiative, Mount St. Mary’s (Victoria) has developed tools and guidelines to support a team approach to meaningful medication reviews in residential care. These can be modified to suit your particular care setting if required.

Medical QI and Pharm Review
Medical QI and Interdisciplinary Team Medication Review
Chart Reviews by Medical Coordinator
Interdisciplinary Team Medication Reviews

'You Decide' Sheets

The following summaries have been compiled and reviewed by an expert clinical advisory group to inform medication reviews and decision making. The materials are continually modified and improved in response to feedback from the field.

Osteoporosis Drugs in the Frail Elderly in Residential Care

Antihypertensive use in the elderly in Residential Care

Proton Pump Inhibitors (PPIs) for the Elderly in Residential Care

Statins in the Older Adult

Antipsychotics in the Treatment of Behavioural and Psychological Symptoms of Dementia (BPSD) in the Elderly


Video series - goals of care conversations

In this video series, residential care experts Gina Gaspard and Dr Trevor Janz, walk you through some difficult conversations with families around end of life goals of care. Conversations cover sensitive issues, such as; what to expect as a loved one's disease progresses (using dementia as one example); use of antibiotics, hospitilization vs comfort care, and others.